$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 13 14 15 16 17 18 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.55 | 135 | 11,010 | 4,988 | 5.1 K to 5 K (-2.64 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.52 | 33 | 2,690 | 5,123 | 5.2 K to 5.1 K (-0.64 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.50 | 623 | 50,775 | 5,156 | 5.8 K to 5.2 K (-10.78 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.34 | 178 | 14,478 | 5,779 | 6 K to 5.8 K (-2.99 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.30 | 293 | 23,821 | 5,957 | 6.3 K to 6 K (-4.69 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.20 | 31 | 2,517 | 6,250 | 6.3 K to 6.3 K (-0.49 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.06 | 289 | 23,425 | 6,281 | 6.6 K to 6.3 K (-4.40 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.00 | 946 | 76,626 | 6,570 | 7.5 K to 6.6 K (-12.59 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,450 | 24,379 | 39,850 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.81 | 12 | 982 | 2,890 | 2.9 K to 2.9 K (-0.41 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.80 | 18 | 1,472 | 2,902 | 2.9 K to 2.9 K (-0.62 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.70 | 87 | 7,108 | 2,920 | 3 K to 2.9 K (-2.89 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.55 | 71 | 5,790 | 3,007 | 3.1 K to 3 K (-2.31 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.52 | 20 | 1,630 | 3,078 | 3.1 K to 3.1 K (-0.65 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.50 | 327 | 26,651 | 3,098 | 3.4 K to 3.1 K (-9.55 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.34 | 93 | 7,564 | 3,425 | 3.5 K to 3.4 K (-2.64 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.30 | 153 | 12,439 | 3,518 | 3.7 K to 3.5 K (-4.17 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.20 | 17 | 1,380 | 3,671 | 3.7 K to 3.7 K (-0.46 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.06 | 153 | 12,402 | 3,688 | 3.8 K to 3.7 K (-3.98 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 81.00 | 499 | 40,419 | 3,841 | 4.3 K to 3.8 K (-11.50 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,450 | 24,379 | 4,340 | 2.9 K to 4.3 K (+50.17 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 9,564 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.81 | 6 | 491 | 4,255 | 4.3 K to 4.3 K (-0.14 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.80 | 10 | 818 | 4,261 | 4.3 K to 4.3 K (-0.23 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.70 | 48 | 3,922 | 4,271 | 4.3 K to 4.3 K (-1.11 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.55 | 39 | 3,181 | 4,319 | 4.4 K to 4.3 K (-0.89 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.52 | 12 | 978 | 4,358 | 4.4 K to 4.4 K (-0.27 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.50 | 179 | 14,589 | 4,370 | 4.5 K to 4.4 K (-3.93 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.34 | 52 | 4,230 | 4,549 | 4.6 K to 4.5 K (-1.13 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.30 | 84 | 6,829 | 4,601 | 4.7 K to 4.6 K (-1.79 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.20 | 10 | 812 | 4,685 | 4.7 K to 4.7 K (-0.21 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.06 | 84 | 6,809 | 4,695 | 4.8 K to 4.7 K (-1.76 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 81.00 | 274 | 22,194 | 4,779 | 5.1 K to 4.8 K (-5.42 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,053 | 4.3 K to 5.1 K (+18.75 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 287 | 6,845 | 147,500 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 2,213 | 52,780 | 147,787 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 83.00 | 175 | 14,525 | 975 | 1.2 K to 975 (-15.22 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 287 | 6,845 | 1,150 | 863 to 1.2 K (+33.26 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 81.00 | 1,350 | 109,350 | 863 | 2.2 K to 863 (-61.00 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 2,213 | 52,780 | 2,213 | 0 to 2.2 K |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 750 | 4,875 | 35,000 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.81 | 6 | 491 | 5,577 | 5.6 K to 5.6 K (-0.11 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.80 | 9 | 736 | 5,583 | 5.6 K to 5.6 K (-0.16 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.70 | 46 | 3,758 | 5,592 | 5.6 K to 5.6 K (-0.82 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.55 | 37 | 3,017 | 5,638 | 5.7 K to 5.6 K (-0.65 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.52 | 6 | 489 | 5,675 | 5.7 K to 5.7 K (-0.11 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.50 | 173 | 14,100 | 5,681 | 5.9 K to 5.7 K (-2.96 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.34 | 49 | 3,986 | 5,854 | 5.9 K to 5.9 K (-0.83 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.30 | 77 | 6,260 | 5,903 | 6 K to 5.9 K (-1.29 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.20 | 10 | 812 | 5,980 | 6 K to 6 K (-0.17 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.06 | 79 | 6,403 | 5,990 | 6.1 K to 6 K (-1.30 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 81.00 | 258 | 20,898 | 6,069 | 6.3 K to 6.1 K (-4.08 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 750 | 4,875 | 6,327 | 5.6 K to 6.3 K (+13.45 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 4,000 | 21,000 | 36,000 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 4.25 | 2,650 | 11,263 | 0 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.81 | 32 | 2,618 | 34,199 | 34.2 K to 34.2 K (-0.09 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.80 | 49 | 4,008 | 34,231 | 34.3 K to 34.2 K (-0.14 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.70 | 243 | 19,853 | 34,280 | 34.5 K to 34.3 K (-0.70 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.55 | 195 | 15,903 | 34,523 | 34.7 K to 34.5 K (-0.56 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.52 | 50 | 4,076 | 34,718 | 34.8 K to 34.7 K (-0.14 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.50 | 906 | 73,839 | 34,768 | 35.7 K to 34.8 K (-2.54 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.34 | 259 | 21,067 | 35,674 | 35.9 K to 35.7 K (-0.72 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.30 | 420 | 34,146 | 35,933 | 36.4 K to 35.9 K (-1.16 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.20 | 49 | 3,979 | 36,353 | 36.4 K to 36.4 K (-0.13 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.06 | 421 | 34,124 | 36,402 | 36.8 K to 36.4 K (-1.14 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.00 | 1,376 | 111,456 | 36,823 | 38.2 K to 36.8 K (-3.60 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 5.25 | 4,000 | 21,000 | 38,199 | 34.2 K to 38.2 K (+11.70 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.81 | 22 | 1,800 | 34,199 | 34.2 K to 34.2 K (-0.06 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.80 | 32 | 2,618 | 34,221 | 34.3 K to 34.2 K (-0.09 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.70 | 161 | 13,154 | 34,253 | 34.4 K to 34.3 K (-0.47 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.55 | 130 | 10,602 | 34,414 | 34.5 K to 34.4 K (-0.38 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.52 | 31 | 2,527 | 34,544 | 34.6 K to 34.5 K (-0.09 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.50 | 601 | 48,982 | 34,575 | 35.2 K to 34.6 K (-1.71 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.34 | 172 | 13,990 | 35,176 | 35.3 K to 35.2 K (-0.49 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.30 | 278 | 22,601 | 35,348 | 35.6 K to 35.3 K (-0.78 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.20 | 32 | 2,598 | 35,626 | 35.7 K to 35.6 K (-0.09 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.06 | 279 | 22,615 | 35,658 | 35.9 K to 35.7 K (-0.78 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 81.00 | 912 | 73,872 | 35,937 | 36.8 K to 35.9 K (-2.47 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 4.25 | 2,650 | 11,263 | 36,849 | 34.2 K to 36.8 K (+7.75 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | M | 6.50 | 10,000 | 65,000 | 5,000 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.81 | 82 | 6,708 | 23,868 | 24 K to 23.9 K (-0.34 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.80 | 121 | 9,898 | 23,950 | 24.1 K to 24 K (-0.50 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.70 | 608 | 49,674 | 24,071 | 24.7 K to 24.1 K (-2.46 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.55 | 489 | 39,880 | 24,679 | 25.2 K to 24.7 K (-1.94 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.52 | 118 | 9,619 | 25,168 | 25.3 K to 25.2 K (-0.47 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.50 | 2,267 | 184,761 | 25,286 | 27.6 K to 25.3 K (-8.23 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.34 | 648 | 52,707 | 27,553 | 28.2 K to 27.6 K (-2.30 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.30 | 1,052 | 85,528 | 28,201 | 29.3 K to 28.2 K (-3.60 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.20 | 123 | 9,988 | 29,253 | 29.4 K to 29.3 K (-0.42 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.06 | 1,052 | 85,271 | 29,376 | 30.4 K to 29.4 K (-3.46 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 81.00 | 3,440 | 278,640 | 30,428 | 33.9 K to 30.4 K (-10.16 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Buy | M | 6.50 | 10,000 | 65,000 | 33,868 | 23.9 K to 33.9 K (+41.90 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 467 | 10,064 | 5,596 | |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.81 | 4 | 327 | 0 | 4 to 0 (-100.00 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.80 | 6 | 491 | 4 | 10 to 4 (-60.00 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.70 | 28 | 2,288 | 10 | 38 to 10 (-73.68 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.55 | 23 | 1,876 | 38 | 61 to 38 (-37.70 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.52 | 6 | 489 | 61 | 67 to 61 (-8.96 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.50 | 105 | 8,558 | 67 | 172 to 67 (-61.05 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.34 | 30 | 2,440 | 172 | 202 to 172 (-14.85 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.30 | 49 | 3,984 | 202 | 251 to 202 (-19.52 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.20 | 6 | 487 | 251 | 257 to 251 (-2.33 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.06 | 49 | 3,972 | 257 | 306 to 257 (-16.01 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 81.00 | 161 | 13,041 | 306 | 467 to 306 (-34.48 %) |
Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 21.55 | 467 | 10,064 | 467 | 0 to 467 |
May 17 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Option Exercise | M | 20.31 | 10,000 | 203,130 | 0 | |
May 17 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 78.50 | 5,170 | 405,845 | 3,555 | 8.7 K to 3.6 K (-59.26 %) |
May 17 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 78.52 | 730 | 57,320 | 8,725 | 9.5 K to 8.7 K (-7.72 %) |
May 17 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 78.51 | 100 | 7,851 | 9,455 | 9.6 K to 9.5 K (-1.05 %) |
May 17 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 78.20 | 2,000 | 156,400 | 9,555 | 11.6 K to 9.6 K (-17.31 %) |
May 17 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Sell | S | 78.05 | 2,000 | 156,100 | 11,555 | 13.6 K to 11.6 K (-14.75 %) |
May 17 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Buy | M | 20.31 | 10,000 | 203,130 | 13,555 | 3.6 K to 13.6 K (+281.29 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 2,000 | 43,100 | 8,760 | |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 73.51 | 408 | 29,993 | 0 | 408 to 0 (-100.00 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 73.50 | 1,085 | 79,748 | 408 | 1.5 K to 408 (-72.67 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 73.42 | 234 | 17,181 | 1,493 | 1.7 K to 1.5 K (-13.55 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 72.93 | 70 | 5,105 | 1,727 | 1.8 K to 1.7 K (-3.90 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 72.62 | 35 | 2,542 | 1,797 | 1.8 K to 1.8 K (-1.91 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 72.55 | 35 | 2,539 | 1,832 | 1.9 K to 1.8 K (-1.87 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 72.51 | 82 | 5,946 | 1,867 | 1.9 K to 1.9 K (-4.21 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 72.50 | 51 | 3,698 | 1,949 | 2 K to 1.9 K (-2.55 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 2,000 | 43,100 | 2,000 | 0 to 2 K |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,750 | 24,750 | 7,905 | |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.51 | 562 | 41,313 | 4,766 | 5.3 K to 4.8 K (-10.55 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.50 | 1,492 | 109,662 | 5,328 | 6.8 K to 5.3 K (-21.88 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.42 | 321 | 23,569 | 6,820 | 7.1 K to 6.8 K (-4.50 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.93 | 95 | 6,928 | 7,141 | 7.2 K to 7.1 K (-1.31 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.62 | 49 | 3,559 | 7,236 | 7.3 K to 7.2 K (-0.67 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.55 | 48 | 3,482 | 7,285 | 7.3 K to 7.3 K (-0.65 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.51 | 112 | 8,122 | 7,333 | 7.4 K to 7.3 K (-1.50 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.50 | 71 | 5,148 | 7,445 | 7.5 K to 7.4 K (-0.94 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,450 | 24,379 | 41,300 | |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 73.51 | 296 | 21,759 | 2,890 | 3.2 K to 2.9 K (-9.29 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 73.50 | 787 | 57,845 | 3,186 | 4 K to 3.2 K (-19.81 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 73.42 | 169 | 12,409 | 3,973 | 4.1 K to 4 K (-4.08 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 72.93 | 51 | 3,719 | 4,142 | 4.2 K to 4.1 K (-1.22 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 72.62 | 25 | 1,816 | 4,193 | 4.2 K to 4.2 K (-0.59 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 72.55 | 25 | 1,814 | 4,218 | 4.2 K to 4.2 K (-0.59 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 72.51 | 59 | 4,278 | 4,243 | 4.3 K to 4.2 K (-1.37 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 72.50 | 38 | 2,755 | 4,302 | 4.3 K to 4.3 K (-0.88 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,450 | 24,379 | 4,340 | 2.9 K to 4.3 K (+50.17 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 10,362 | |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 73.51 | 163 | 11,982 | 4,255 | 4.4 K to 4.3 K (-3.69 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 73.50 | 433 | 31,826 | 4,418 | 4.9 K to 4.4 K (-8.93 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 73.42 | 93 | 6,828 | 4,851 | 4.9 K to 4.9 K (-1.88 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 72.93 | 28 | 2,042 | 4,944 | 5 K to 4.9 K (-0.56 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 72.62 | 14 | 1,017 | 4,972 | 5 K to 5 K (-0.28 %) |
May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 72.55 | 14 | 1,016 | 4,986 | 5 K to 5 K (-0.28 %) |